New Options in Herpes Treatments
Viradux Research, LTD announced today that it has released to market Viradux-ColdSore (TM) as the only effective anti-herpetic HSV1 treatment currently available based on type-III epidermal transportation compounds. Viraudx-ColdSore lip balm has been shown to speed healing of existing herpetic lesions and prevent the reoccurrence of future outbreaks associated with moderate-to-severe Herpes Simplex Virus (HSV-1) infection.
View full press release